Key Laboratory of Hubei Province for Coal Conversion and New Carbon Materials; School of Chemistry and Chemical Engineering, Wuhan University of Science and Technology, Wuhan 430081, P. R. China.
Dalton Trans. 2020 Dec 15;49(47):17157-17163. doi: 10.1039/d0dt03090b.
Photoactivatable diazidodihydroxido Pt(iv) complex trans,trans,trans-[Pt(N3)2(OH)2(py)2] (1; py = pyridine) is a promising anticancer agent which can be activated by visible light to induce cancer cell death. DNA has been thought to be involved in the mechanism of action of this kind of Pt(iv) prodrug. However, the detailed photodecomposition pathways of complex 1 and its interaction modes with DNA are complex. Herein we report that upon light irradiation complex 1 can bind to all four nucleosides covalently with the reduced Pt(ii) species. Moreover, apart from the covalent coordination, various oxidation adducts of these four nucleosides induced by the reactive oxidative species (ROS) generated during the photoactivation of the complex 1 have also been identified, especially the induced oxidation of adenosine and cytidine which was firstly reported for this kind of photoactivatable Pt(iv) prodrug. Such dual-action may contribute to the highly potent photo-antiproliferativity of complex 1 towards cancer cells, which may account for the unique mechanism of action of the photoactivatable diazido Pt(iv) anticancer complexes.
光活化叠氮二羟基合铂(IV)配合物顺式,反式,反式-[Pt(N3)2(OH)2(py)2](1; py =吡啶)是一种很有前途的抗癌剂,可通过可见光激活诱导癌细胞死亡。人们认为 DNA 参与了这种铂(IV)前药的作用机制。然而,复合物 1 的详细光分解途径及其与 DNA 的相互作用模式很复杂。在这里,我们报道了在光照下,复合物 1 可以与所有四个核苷发生共价键合,生成还原的 Pt(ii)物种。此外,除了由复合物 1 的光激活过程中产生的活性氧(ROS)引起的各种核苷的氧化加合物之外,还鉴定了这些四种核苷的各种氧化加合物,特别是对腺嘌呤和胞嘧啶的诱导氧化,这是首次报道了这种光活化的铂(IV)前药。这种双重作用可能有助于复合物 1 对癌细胞具有很强的光抗增殖活性,这可能解释了光活化叠氮铂(IV)抗癌配合物的独特作用机制。